Quil A、PICKCa對FMDV、PCV2-PRRSV DNA疫苗免疫增強作用的效果觀察
[Abstract]:Quil A is a triterpenoid saponins extracted from the bark of Quillaja soap Molina, South America. It contains at least five different saponins by high performance liquid chromatography (HPLC). It is a surfactant, soluble in water, stable and has good surface activity. Saponins with auxiliary properties. In 1936, they were first deployed as adjuvants in veterinary vaccines by Thibaulu and Richou. PICKCA is an improved adjuvant that is complex based on polynucleotides. The polymyocytes themselves have toxic effects on human body, but also have a strong adjuvant effect. Kanamycin and calcium chloride can be hydrolyzed rapidly. As a positively charged molecule, kanamycin can neutralize the negative charge of the polymyocytes, making the polymyocytes more stable and anti-hydrolysis. The addition of calcium chloride was beneficial to polymyocytes entering the cells. In short, PICKCa is a stable and safe adjuvant. To explore the regulatory effect of QuilA,PICKCa and its combination on immune response of experimental animals, QuilA,PICKCa and its mixture were injected into mice and pigs respectively. Blood samples were collected at different time after injection to detect cytokine level. The proliferation of porcine T lymphocytes in vitro was detected on the 7th day after injection. The results showed that there were no adverse reactions in mice and pigs after injection of drugs, and the levels of IFN- 緯 and IL-2,IL-4,IL-10 in the experimental group were significantly higher than those in the control group. The proliferation ability of porcine T lymphocytes in vitro was also significantly higher than that of the control group. It is concluded that QuilA,PICKCa has a good immunomodulatory effect on mice and pigs, and it is a promising immunoadjuvant. In order to study the immunoenhancement effect of Quil A on DNA vaccine of type O foot-and-mouth disease (FMD), Quil A was added to FMD nucleic acid vaccine pVIRIL18P1 to immunize pigs by intramuscular injection to detect the level of VP1 structural protein antibody and cytokines, and to observe the proliferation of T lymphocytes. And compared with the non-adjuvant group. The results showed that the level of antibody, the level of cytokines and the proliferation rate of T lymphocytes were significantly increased after two times of immunization with the addition of Quil A into the nucleic acid vaccine pVIRIL18P1 and the recombinant fowlpox vaccine vUTAL3CP1 for the first and second immunization of swine foot-and-mouth disease (FMD), respectively. Compared with the blank control group, the difference was significant (P0.05) or extremely significant (P0.01), and significantly different from the non-adjuvant group and commercial vaccine. The results showed that Quil A had a better immune enhancement effect on DNA vaccine of type O foot-and-mouth disease (FMD). In order to study the immunoenhancement effect of PICKCa on porcine reproductive and respiratory syndrome (PRRS) and porcine circovirus type 2 (PCV) vaccine, PICKCa, was added to the pIRES-ORF2-ORF5m-ORF6a vaccine to immunize pigs by intramuscular injection. The antibody and cytokine levels of porcine reproductive and respiratory syndrome (PRRS) and porcine circovirus type 2 virus (PRV-2) were detected. The proliferation of T lymphocytes was observed and compared with that of non-adjuvant group. The results of porcine immunity test showed that the recombinant nucleic acid vaccine combined with PICKCa could stimulate the production of PRRSV,PCV2 antibody in experimental pigs. The results of cellular immunoassays showed that PRRSV,PCV2-specific T lymphocytes proliferated, the secretion of IFN- 緯 and IL-2 increased significantly, and the killing activity of CTL increased, which indicated that it could mediate better Th1-like immune response. Recombinant nucleic acid vaccine vaccinated swine tissues and organs without pathological damage, can prevent the occurrence of swine viremia. The experimental results showed that the recombinant nucleic acid vaccine supplemented with PICKCa adjuvant could significantly enhance the immune protection of experimental pigs.
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2012
【分類號】:R392
【參考文獻】
相關(guān)期刊論文 前9條
1 胡佳杰,肖愛清,黃海浪,皇甫永穆;重組恥垢分枝桿菌-Sj26GST疫苗的免疫保護作用研究[J];疾病控制雜志;2003年03期
2 許波;聚肌胞治療單純皰疹病毒性角膜炎療效觀察[J];江西醫(yī)藥;2000年06期
3 趙振華;羅家鑄;皇甫玉珩;禹旺盛;佟程浩;李康隆;石立經(jīng);;單純型豬瘟的病理學(xué)研究及干擾素誘導(dǎo)劑聚肌胞(POLYI∶C)對豬瘟的保護性作用的探討[J];內(nèi)蒙古農(nóng)牧學(xué)院學(xué)報;1983年01期
4 江文正,金寧一,李子健,張立樹,王宏,金洪濤;IL-18和HIV-1gag-gp120嵌合基因DNA疫苗聯(lián)合免疫小鼠的免疫應(yīng)答[J];細(xì)胞與分子免疫學(xué)雜志;2004年04期
5 王春林;聚肌胞的藥理和臨床應(yīng)用[J];江蘇醫(yī)藥;1992年05期
6 路青華;干擾素聯(lián)合聚肌胞治療慢性乙型肝炎療效觀察[J];中國綜合臨床;2004年01期
7 鄧光明;;口蹄疫滅活疫苗研究進展與應(yīng)用[J];中國豬業(yè);2009年11期
8 馮長建;田延武;趙修竹;;聚肌胞對小鼠移植性腫瘤生長的影響[J];腫瘤防治研究;1984年01期
9 李瑞麗;胡松華;;玉屏風(fēng)散及其麥冬加味對O型口蹄疫疫苗免疫反應(yīng)的影響[J];中國獸醫(yī)學(xué)報;2010年02期
相關(guān)碩士學(xué)位論文 前1條
1 計越;口蹄疫病毒基因重組疫苗的實驗免疫研究[D];吉林大學(xué);2007年
本文編號:2455223
本文鏈接:http://sikaile.net/xiyixuelunwen/2455223.html